AAAAAA
Results: 26-32/32
Authors:
ELMOUSSAOUI A
CHAUVET A
MASSE J
GAUDY D
PUECH A
Citation: A. Elmoussaoui et al., LYOAVAILABILITY OF NORDAZEPAM SOLID DISPERSIONS IN RELATION WITH PHASE-DIAGRAMS, International journal of pharmaceutics, 106(2), 1994, pp. 109-114
Authors:
PATAT A
MOLINIER P
HERGUETA T
BROHIER S
ZIELENIUK I
DANJOU P
WAROT D
PUECH A
Citation: A. Patat et al., LACK OF AMNESTIC, PSYCHOTOMIMETIC OR IMPAIRING EFFECT ON PSYCHOMOTOR PERFORMANCE OF ELIPRODIL, A NEW NMDA ANTAGONIST, International clinical psychopharmacology, 9(3), 1994, pp. 155-162
Authors:
BISSERBE JC
PUECH A
BOURIN M
BOYER P
DELALLEAU A
GARREAU M
MAGNI G
LEPINE JP
LECRUBIER Y
SOUETRE E
Citation: Jc. Bisserbe et al., LONG-TERM EVALUATION OF THERAPIES IN DEPR ESSED AND ANXIOUS DISORDERS, Therapie, 49(3), 1994, pp. 251-260
Authors:
HENRY I
HOOVERS J
BARICHARD F
BERTHEAS MF
PUECH A
PRIEUR F
GESSLER M
BRUNS G
MANNENS M
JUNIEN C
Citation: I. Henry et al., PERICENTRIC INTRACHROMOSOMAL INSERTION RESPONSIBLE FOR RECURRENCE OF DEL(11)(P13P14) IN A FAMILY, Genes, chromosomes & cancer, 7(1), 1993, pp. 57-62
Authors:
HOURRI O
GAUDY D
PUECH A
MASSE J
Citation: O. Hourri et al., THERMAL-ANALYSIS, SPECTROSCOPY AND LYOAVA ILABILITY OF SOLID DISPERSIONS OF OXAZEPAM AND POLYOXYETHYLENE GLYCOL-4000 AND POLYOXYETHYLENE GLYCOL-6000, Journal of thermal analysis, 39(10), 1993, pp. 1273-1284
Authors:
PUECH A
Citation: A. Puech, THE CONTROLLED TRIALS, Therapie, 48(5), 1993, pp. 427-427
Authors:
DAHAN R
JAILLON P
LEHNER JP
CAZOR JL
CLOARECBLANCHARD L
DAHAN R
DUCHIER J
GUINOT P
JAILLON P
LEHNER JP
LOEB F
MACQUINMAVIER C
PUECH A
ROLAND E
ROUVEIX B
TEULEESPIE M
THULLIEZ C
VITOU P
Citation: R. Dahan et al., HOW TO PREDICT THE THERAPEUTIC DOSE RANGE TO BE TESTED IN PHASE-III CLINICAL-TRIALS, Therapie, 48(4), 1993, pp. 297-301